Logothetis CJ - Search Results

1

Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment.

Subudhi SK, Siddiqui BA, Aparicio AM, Yadav SS, Basu S, Chen H, Jindal S, Tidwell RSS, Varma A, Logothetis CJ, Allison JP, Corn PG, Sharma P. Subudhi SK, et al. Among authors: logothetis cj. J Immunother Cancer. 2021 Oct;9(10):e002919. doi: 10.1136/jitc-2021-002919. J Immunother Cancer. 2021. PMID: 34663638 Free PMC article.

2

Chemotherapy for small cell carcinoma of prostatic origin.

Amato RJ, Logothetis CJ, Hallinan R, Ro JY, Sella A, Dexeus FH. Amato RJ, et al. Among authors: logothetis cj. J Urol. 1992 Mar;147(3 Pt 2):935-7. doi: 10.1016/s0022-5347(17)37427-x. J Urol. 1992. PMID: 1311396

3

Fluorouracil and recombinant human interferon alfa-2a in the treatment of metastatic chemotherapy-refractory urothelial tumors.

Logothetis CJ, Hossan E, Sella A, Dexeus FH, Amato RJ. Logothetis CJ, et al. J Natl Cancer Inst. 1991 Feb 20;83(4):285-8. doi: 10.1093/jnci/83.4.285. J Natl Cancer Inst. 1991. PMID: 1994058 Clinical Trial.

4

Interferon alternating with chemotherapy for patients with metastatic renal cell carcinoma.

Dexeus FH, Logothetis CJ, Sella A, Finn L. Dexeus FH, et al. Among authors: logothetis cj. Am J Clin Oncol. 1989 Aug;12(4):350-4. doi: 10.1097/00000421-198908000-00015. Am J Clin Oncol. 1989. PMID: 2667326 Clinical Trial.

5

Clinical and radiological correlation of retroperitoneal metastasis from nonseminomatous testicular cancer treated with chemotherapy.

Dexeus FH, Shirkhoda A, Logothetis CJ, Chong C, Sella A, Ogden S, Swanson D. Dexeus FH, et al. Among authors: logothetis cj. Eur J Cancer Clin Oncol. 1989 Jan;25(1):35-43. doi: 10.1016/0277-5379(89)90048-5. Eur J Cancer Clin Oncol. 1989. PMID: 2920767

6

Adjuvant chemotherapy of bladder cancer: a preliminary report.

Logothetis CJ, Johnson DE, Chong C, Dexeus FH, Ogden S, von Eschenbach A, Ayala A. Logothetis CJ, et al. J Urol. 1988 Jun;139(6):1207-11. doi: 10.1016/s0022-5347(17)42861-8. J Urol. 1988. PMID: 3373589

7

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Sella A, Kilbourn R, Amato R, Bui C, Zukiwski AA, Ellerhorst J, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. J Clin Oncol. 1994 Apr;12(4):683-8. doi: 10.1200/JCO.1994.12.4.683. J Clin Oncol. 1994. PMID: 7512126 Clinical Trial.

8

Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancer.

Sella A, Aggarwal BB, Kilbourn RG, Bui CA, Zukiwski AA, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. Cancer Biother. 1995 Fall;10(3):225-35. doi: 10.1089/cbr.1995.10.225. Cancer Biother. 1995. PMID: 8547961 Clinical Trial.

9

Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma.

Ellerhorst JA, Sella A, Amato RJ, Tu SM, Millikan RE, Finn LD, Banks M, Logothetis CJ. Ellerhorst JA, et al. Among authors: logothetis cj. Cancer. 1997 Dec 1;80(11):2128-32. Cancer. 1997. PMID: 9392335 Clinical Trial.

10

Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancer.

Tu SM, Pagliaro LC, Banks ME, Amato RJ, Millikan RE, Bugazia NA, Madden T, Newman RA, Logothetis CJ. Tu SM, et al. Among authors: logothetis cj. Clin Cancer Res. 1998 May;4(5):1193-201. Clin Cancer Res. 1998. PMID: 9607577 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

422 results

Search Page

Filters